Sovran Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Sovran Advisors, LLC
- $954 Billion
- Q2 2025
A detailed history of Sovran Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sovran Advisors, LLC holds 5,020 shares of REGN stock, worth $2.77 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
5,020Holding current value
$2.77 Million% of portfolio
0.29%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,467Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.2 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.67 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.13 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.65 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.2 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $59.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...